Side-by-side comparison of AI visibility scores, market position, and capabilities
Goleta CA performance footwear (NYSE: DECK) ~$4.9B FY2025 revenue; HOKA $2.2B (+16%), UGG $2.3B Gen Z resurgence, 45%+ DTC mix, competing with Nike, On Running and Skechers.
Deckers Brands is a Goleta, California-based footwear and apparel company — publicly traded on the New York Stock Exchange (NYSE: DECK) as an S&P 500 Consumer Discretionary component — designing, marketing, and distributing footwear through four brands: HOKA (performance athletic running and trail shoes), UGG (sheepskin boots, slippers, and casual footwear), Teva (sport sandals), and Koolaburra (accessible sheepskin-style footwear) through approximately 4,300 employees globally. In fiscal year 2025 (ending March 2025), Deckers reported revenues of approximately $4.9 billion with HOKA generating over $2.2 billion (+16% growth) representing the most successful performance footwear brand launch in recent industry history — and UGG generating approximately $2.3 billion in its strongest year yet driven by the sheepskin boot cultural resurgence among Gen Z consumers embracing comfort-forward casual fashion. CEO Dave Powers has executed a brand portfolio strategy that counterintuitively benefits from multi-brand diversity: when outdoor athletic trends favor performance running (HOKA gains), casual comfort trends favor UGG, with the two largest brands often running on different consumer cycle timing. The direct-to-consumer expansion (DTC revenue growing to 45%+ of total sales) captures higher margins than wholesale channel sales — an UGG boot sold through deckers.com or an owned retail store generates 3-4x the gross margin dollar versus the same boot sold through Nordstrom or Dick's Sporting Goods, funding brand investment and driving customer lifetime value through owned digital relationships.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.